News Digest / Ticker: BX

Ticker: BX

02:47am, Thursday, May 28, 2026
Apogee Therapeutics shares surge nearly 16% pre-market following a $1.3 billion financing deal with Blackstone Life Sciences to support its atopic dermatitis drug, zumilokibart.